Posted in | News | Nanobusiness

Evident Technologies to Reorganize Under Bankruptcy Laws

Evident Technologies announced a filing in chapter 11 reorganization today and has asked the Bankruptcy court in Albany, New York to approve a debtor in financing package of $ 1.35 million. The filing was prompted by Evident's inability to continue paying the exorbitant costs associated with a patent infringement case brought on by a large California-based life science company. The promise of substantial debtor in possession financing triggered by a chapter 11 filing was another driving reason for the bankruptcy filing. During the Chapter 11, Evident will operate under current management and continue research in nanotechnology and pursuit of commercialization of its patented technology.

“Defending a lawsuit in the Eastern District of Texas for patent infringement required us to spend at an unsustainable rate,” stated Clinton Ballinger, CEO. “The restructuring plan associated with the chapter 11 allows us to protect our business and operate the company going forward. We have reached an agreement with our secured creditors already and our customers and employees should see minimal impact.”

Chapter 11 of the Bankruptcy Code allows companies to reorganize under the bankruptcy laws of the US if they are unable to service their debt. Evident has developed a plan with major creditors for operating the company going forward.

Founded in 2000, Evident Technologies develops and commercializes technology based on semiconductor nanocrystals. Evident is one of the first companies to commercialize products based on semiconductor nanotechnology and has launched commercial products in LED and lighting, military and life science markets.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.